Literature DB >> 33934244

Investigation of tautomerism of 1,3,5-triazine derivative, stability, and acidity of its tautomers from density functional theory.

Lucie Affoue Bede1, Alain Kouassi Koffi2, Fred-Lawson Ekozias Digre Beke2, Abderrahmane Semmeq3, Michael Badawi4.   

Abstract

Recent studies have identified N2,N4-bis(4-fluorophenethyl)-N6-(3-(dimethylamino)propyl)-1,3,5-triazine-2,4,6-triamine (1TZ(7,8,9)) as a potent, pure antagonist that inhibits thermosensory transient receptor potential vanilloid 1 channel (TRPV1) channel activity. This study provides theoretical data on the stability and acidity of the tautomers of this molecule. We show that this triazine can exist as three predominant tautomers (2TZ(5,7,8), 4TZ(3,7,9), 7TZ(1,8,9)). In the aqueous phase, equilibrium constants calculations show that only the tautomeric equilibria between 1TZ(7,8,9) and the three most stable triazines can be present which suggests that these three tautomeric equilibria would be the basis of 1TZ(7,8,9)'s biological activity.

Entities:  

Keywords:  1,3,5-Triazine; Acidity; DFT; Stability; Tautomerism

Year:  2021        PMID: 33934244     DOI: 10.1007/s00894-021-04774-5

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  17 in total

1.  Triazine-based vanilloid 1 receptor open channel blockers: design, synthesis, evaluation, and SAR analysis.

Authors:  Miquel Vidal-Mosquera; Asia Fernández-Carvajal; Alejandra Moure; Pierluigi Valente; Rosa Planells-Cases; José M González-Ros; Jordi Bujons; Antonio Ferrer-Montiel; Angel Messeguer
Journal:  J Med Chem       Date:  2011-10-10       Impact factor: 7.446

2.  An inhibitor of TRPV1 channels isolated from funnel Web spider venom.

Authors:  Tetsuya Kitaguchi; Kenton J Swartz
Journal:  Biochemistry       Date:  2005-11-29       Impact factor: 3.162

3.  Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.

Authors:  Tihomir Tomašić; Andreja Kovač; Gerhard Klebe; Didier Blanot; Stanislav Gobec; Danijel Kikelj; Lucija Peterlin Mašič
Journal:  J Mol Model       Date:  2011-06-12       Impact factor: 1.810

4.  Anti-inflammatory activity of triazine derivatives: A systematic review.

Authors:  Laura Marín-Ocampo; Luz Angela Veloza; Rodrigo Abonia; Juan C Sepúlveda-Arias
Journal:  Eur J Med Chem       Date:  2018-11-13       Impact factor: 6.514

5.  Triazine-based tyrosinase inhibitors identified by chemical genetic screening.

Authors:  Li Ni-Komatsu; Jennifer K Leung; Darren Williams; Jaeki Min; Sonya M Khersonsky; Young-Tae Chang; Seth J Orlow
Journal:  Pigment Cell Res       Date:  2005-12

Review 6.  1,3,5-Triazines: A promising scaffold for anticancer drugs development.

Authors:  Stella Cascioferro; Barbara Parrino; Virginia Spanò; Anna Carbone; Alessandra Montalbano; Paola Barraja; Patrizia Diana; Girolamo Cirrincione
Journal:  Eur J Med Chem       Date:  2017-10-06       Impact factor: 6.514

7.  Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.

Authors:  Hans Raj Bhat; Udaya Pratap Singh; Anjali Thakur; Surajit Kumar Ghosh; Kabita Gogoi; Anil Prakash; Ramendra K Singh
Journal:  Exp Parasitol       Date:  2015-07-09       Impact factor: 2.011

8.  Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons.

Authors:  Ian R Mellor; Jane Ogilvie; Florentina Pluteanu; Richard H Clothier; Terence L Parker; Michela Rosini; Anna Minarini; Vincenzo Tumiatti; Carlo Melchiorre
Journal:  Eur J Pharmacol       Date:  2004-11-28       Impact factor: 4.432

9.  Antiviral activity and interaction mechanisms study of novel glucopyranoside derivatives.

Authors:  Meihang Chen; Deyu Hu; Xiangyang Li; Song Yang; Weiying Zhang; Pei Li; Baoan Song
Journal:  Bioorg Med Chem Lett       Date:  2015-07-26       Impact factor: 2.823

10.  Solvatochromic effect in absorption and emission spectra of star-shaped bipolar derivatives of 1,3,5-triazine and carbazole. A time-dependent density functional study.

Authors:  Gleb V Baryshnikov; Sergey V Bondarchuk; Valentina A Minaeva; Hans Ågren; Boris F Minaev
Journal:  J Mol Model       Date:  2017-02-04       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.